COMPOUND OVERVIEW

Ipamorelin is a selective pentapeptide growth hormone secretagogue (GHS) and ghrelin receptor agonist that stimulates GH release from the anterior pituitary with high selectivity and minimal off-target effects. Developed as a research tool for studying the GH axis, Ipamorelin is notable for its clean pharmacological profile — it stimulates GH release without meaningfully affecting cortisol, prolactin, or ACTH levels at research-relevant doses. This selectivity has made it a preferred choice in GH research, often combined with GHRH analogues like CJC-1295 to maximize GH pulse amplitude.

MECHANISM OF ACTION

Ipamorelin acts as an agonist at the ghrelin receptor (GHS-R1a) on pituitary somatotrophs, triggering intracellular calcium mobilization and GH exocytosis. Unlike first-generation GHRPs (GHRP-2, GHRP-6), Ipamorelin does not significantly stimulate cortisol, ACTH, or prolactin secretion, making it a cleaner research molecule for studying isolated GH axis effects. Its synergy with GHRH analogues operates through complementary receptor pathways — CJC-1295 increases GH synthesis while Ipamorelin triggers its release — resulting in substantially amplified GH output in combination protocols.

RESEARCH APPLICATIONS

• GH axis research and selective GH secretagogue studies
• Combination GHRH + GHRP protocol research
• GH pulse amplitude and frequency modulation studies
• Body composition, anabolic signaling, and recovery research
• Sleep architecture and GH nocturnal secretion studies
• Clean GH stimulation research with minimal HPA axis interference

KEY RESEARCH FINDINGS

• Research demonstrates significant GH release following Ipamorelin with minimal cortisol or ACTH response
• Combination protocols with CJC-1295 Without DAC show synergistic GH peak amplification of 2–4x over monotherapy
• Studies in aging research models indicate restoration of GH pulse amplitude with Ipamorelin administration
• Body composition research shows favorable lean mass retention and adipose reduction in sustained protocols
• Ipamorelin has been used extensively as a reference compound in GHS receptor binding studies

STORAGE & HANDLING

• Store lyophilized powder at -20°C for up to 24 months
• Reconstitute with bacteriostatic water; store at 2–8°C; use within 28 days
• Protect from light and heat
• Do not freeze after reconstitution
• Use sterile technique in all research procedures

SPECIFICATIONS

DISCLAIMER: This compound is sold strictly for laboratory and research purposes only. It is not intended for human consumption, clinical use, or veterinary application. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. For use by licensed researchers and qualified professionals only. You must be 21 years of age or older to purchase.

usaminopeptides.com · For Researcher Inquiries Contact: info@usaminopeptides.com